4.4 Article

A novel approach to Finafloxacin hydrochloride (BAY35-3377)

期刊

TETRAHEDRON LETTERS
卷 50, 期 21, 页码 2525-2528

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.tetlet.2009.03.051

关键词

Finafloxacin hydrochloride; BAY35-3377; Fluoroquinolone antibiotics

向作者/读者索取更多资源

Finafloxacin hydrochloride, an important clinical compound was synthesized by a novel synthetic approach. An active intermediate ethyl 7-chloro-8-cyano-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylate 19 was prepared by a new route. The chiral (S,S')-N-Boc 10 was derived from protected pyrrolidine and the absolute stereochemistry was established by X-ray analysis. (C) 2009 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Chemistry, Medicinal

Recent developments of 2-aminothiazoles in medicinal chemistry

Debasis Das, Papiya Sikdar, Moumita Bairagi

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)

Review Chemistry, Medicinal

Recent Advancement of Direct-acting Antiviral Agents (DAAs) in Hepatitis C Therapy

Debasis Das, Mayank Pandya

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2018)

Review Biochemistry & Molecular Biology

Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors

Debasis Das, Jian Hong, Shu-Hui Chen, Guangyi Wang, Leonid Beigelman, Scott D. Seiwert, Brad O. Buckman

BIOORGANIC & MEDICINAL CHEMISTRY (2011)

Article Chemistry, Organic

A New Approach to Tubacin

Jian Hong, Xin Xu, Debasis Das, Pengyu Yang, Shu-Hui Chen, Ge Li

LETTERS IN ORGANIC CHEMISTRY (2010)

Article Chemistry, Medicinal

Discovery of new quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors and their anticancer activities - Part 1

Debasis Das, Lingzhi Xie, Jingbing Wang, Xin Xu, Zonghua Zhang, Jingli Shi, Xiaoyong Le, Jian Hong

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)

Review Chemistry, Medicinal

Recent advancements of 4-aminoquinazoline derivatives as kinase inhibitors and their applications in medicinal chemistry

Debasis Das, Jian Hong

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Chemistry, Medicinal

Design, synthesis of orally bioavailable novel anaplastic lymphoma kinase (ALK) inhibitor diphenylaminopyrimidine analogs and efficacy study on NCI-H2228 xenografts mice model

Debasis Das, Jingbing Wang, Yong Li, Jingli Shi, Jian Hong

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)

Review Chemistry, Medicinal

Irreversible Kinase Inhibitors Targeting Cysteine Residues and their Applications in Cancer Therapy

Debasis Das, Jian Hong

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

In vivo efficacy studies of novel quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors, in lung cancer xenografts (NCI-H1975) mice models

Debasis Das, Lingzhi Xie, Jingbing Wang, Jingli Shi, Jian Hong

BIOORGANIC CHEMISTRY (2020)

Review Chemistry, Medicinal

Recent Applications of Azo Dyes: A Paradigm Shift from Medicinal Chemistry to Biomedical Sciences

Md Nasim Khan, Digvijaysinh K. Parmar, Debasis Das

Summary: Azo compounds are widely used in various industries and play important roles in medicinal chemistry, such as antibacterial, antifungal, and antioxidant. However, their application in medicinal chemistry is limited by safety concerns related to metabolic degradation.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2021)

Review Chemistry, Medicinal

Next-Generation Kinase Inhibitors Targeting Specific Biomarkers in Non-Small Cell Lung Cancer (NSCLC): A Recent Overview

Debasis Das, Jingbing Wang, Jian Hong

Summary: Lung cancer is a major cause of global mortality, with mutations in regulatory genes and irregular signal transduction pathways observed in non-small cell lung cancer patients. Several kinases have been identified as targetable biomarkers, leading to the FDA approval of multiple kinase inhibitors for NSCLC treatment.

CHEMMEDCHEM (2021)

Article Biochemistry & Molecular Biology

Design, Synthesis of New Pyrazolo[3,4-d]Pyrimidine Derivatives and In Vitro Evaluation of Antiproliferative Activity against Leukemia Cell Lines

Debasis Das, Lingzhi Xie, Jingbing Wang, Dandan Qiao, Jian Hong

Summary: A series of new pyrazolo[3,4-d]pyrimidine derivatives were synthesized and evaluated for their anti-leukemia activity. All the compounds exhibited good in vitro anti-proliferative activities, with some being more potent than the BTK inhibitor ibrutinib. Promising compounds (IIc, IIk, and III) showed low IC50 values against multiple leukemia cell lines.

RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY (2022)

Review Chemistry, Medicinal

Next-generation Bruton's Tyrosine Kinase (BTK) Inhibitors Potentially Targeting BTK C481S Mutation- Recent Developments and Perspectives

Debasis Das, Jingbing Wang, Jian Hong

Summary: This review summarizes the discovery and development of next-generation BTK inhibitors, especially targeting the BTK C481S mutation, and their applications in the treatment of lymphomas and autoimmune diseases.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2022)

Review Chemistry, Organic

One-pot Synthesis of Pyrano[2,3-c]pyrazole Derivatives via Multicom-ponent Reactions (MCRs) and their Applications in Medicinal Chemistry

Swapan Kumar Biswas, Debasis Das

Summary: This review article compiles the synthesis methods of pyrano[2,3-c]pyrazole derivatives and highlights their applications in medicinal chemistry.

MINI-REVIEWS IN ORGANIC CHEMISTRY (2022)

Article Chemistry, Medicinal

Discovery of Novel, Selective Prostaglandin EP4 Receptor Antagonists with Efficacy in Cancer Models

Debasis Das, Dandan Qiao, Zhonghe Liu, Lingzhi Xie, Yong Li, Jingbing Wang, Jianhe Jia, Yuxi Cao, Jian Hong

Summary: A series of selective EP4 antagonists were identified, and compound 36 was discovered as a potent inhibitor. In vivo efficacy studies showed that compound 36 inhibited tumor growth and a combination with capecitabine significantly suppressed tumor growth in mouse models.

ACS MEDICINAL CHEMISTRY LETTERS (2023)

Article Chemistry, Organic

Pyrrolidine-based C1-symmetric chiral transition metal complexes as catalysts in the asymmetric organic transformations

Geeta Devi Yadav, Pooja Chaudhary, Balaram Pani, Surendra Singh

Summary: Chiral transition metal complexes with privileged ligands are efficient catalysts for various asymmetric organic transformations. Transition metal complexes of C1-symmetric pyrrolidine-based ligands have been widely used in asymmetric organic reactions. However, a comprehensive review article on the transition metal complexes of chiral C1-symmetric pyrrolidine-based ligands derived from (L)-proline has not been published.

TETRAHEDRON LETTERS (2024)